Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material for adaptive...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Screening of the Pandemic Response Box Library Identified CRM1/XPO1 as an Anti-Mammarenavirus Druggable Target.

Viruses·2026
Same author

Pandemic Response Box Screening Identified CRM1/XPO1 as an Anti-Mammarenavirus Druggable Target.

bioRxiv : the preprint server for biology·2025
Same author

Mammarenavirus Z Protein Myristoylation and Oligomerization Are Not Required for Its Dose-Dependent Inhibitory Effect on vRNP Activity.

BioChem·2025
Same author

Repurposing Drugs for Synergistic Combination Therapies to Counteract Monkeypox Virus Tecovirimat Resistance.

Viruses·2025
Same author

Cellular N-Myristoyl Transferases Are Required for Mammarenavirus Multiplication.

Viruses·2024
Same author

Cellular N-myristoyl transferases Are Required for Mammarenavirus Multiplication.

bioRxiv : the preprint server for biology·2024

Related Experiment Video

Updated: Jul 1, 2026

Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells
10:03

Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells

Published on: August 1, 2013

Reverse genetics approaches to combat pathogenic arenaviruses.

Juan C de la Torre1

  • 1Immunology and Microbial Science, IMM-6, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA. juanct@scripps.edu

Antiviral Research
|September 11, 2008
PubMed
Summary

Developing effective vaccines and antiviral drugs is crucial for combating lymphocytic choriomeningitis virus (LCMV) and other dangerous arenaviruses. Research using reverse genetics advances understanding of viral mechanisms for therapeutic development.

More Related Videos

Reverse Genetics to Engineer Positive-Sense RNA Virus Variants
15:49

Reverse Genetics to Engineer Positive-Sense RNA Virus Variants

Published on: June 9, 2022

Arbovirus Infections As Screening Tools for the Identification of Viral Immunomodulators and Host Antiviral Factors
06:02

Arbovirus Infections As Screening Tools for the Identification of Viral Immunomodulators and Host Antiviral Factors

Published on: September 13, 2018

Related Experiment Videos

Last Updated: Jul 1, 2026

Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells
10:03

Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells

Published on: August 1, 2013

Reverse Genetics to Engineer Positive-Sense RNA Virus Variants
15:49

Reverse Genetics to Engineer Positive-Sense RNA Virus Variants

Published on: June 9, 2022

Arbovirus Infections As Screening Tools for the Identification of Viral Immunomodulators and Host Antiviral Factors
06:02

Arbovirus Infections As Screening Tools for the Identification of Viral Immunomodulators and Host Antiviral Factors

Published on: September 13, 2018

Area of Science:

  • Virology
  • Infectious Diseases
  • Vaccinology

Background:

  • Arenaviruses, including lymphocytic choriomeningitis virus (LCMV), cause human hemorrhagic fever (HF) and represent a significant biodefense concern.
  • Current treatments for arenavirus infections are limited, with ribavirin showing partial efficacy and notable side effects.
  • The lack of licensed vaccines necessitates the development of novel therapeutic and preventative strategies.

Purpose of the Study:

  • To highlight the clinical significance of LCMV as a neglected arenavirus pathogen.
  • To emphasize the need for effective vaccines and improved antiviral therapies against arenaviruses.
  • To discuss the role of arenavirus reverse genetics in advancing molecular understanding and drug discovery.

Main Methods:

  • Utilizing arenavirus reverse genetic systems for detailed molecular characterization.
  • Investigating viral cis-acting signals and trans-acting factors governing the arenavirus life cycle.
  • Generating specific mutations within the viral genome to analyze phenotypic expression and host interactions.

Main Results:

  • Reverse genetics enables a comprehensive understanding of arenavirus RNA synthesis, packaging, and budding.
  • Studies are identifying potential novel targets for therapeutic interventions against arenaviruses.
  • Characterization of viral mechanisms aids in developing assays for candidate antiviral drug screening.

Conclusions:

  • Knowledge gained from molecular characterization facilitates the development of novel antiviral drugs.
  • Understanding arenavirus-host interactions can elucidate the mechanisms of severe hemorrhagic fever.
  • The development of effective vaccines and therapies is critical for mitigating arenavirus threats.